Plus   Neg

Alexion Gets Positive Opinion From CHMP For SOLIRIS For Treatment Of NMOSD

Alexion Pharmaceuticals Inc. (ALXN) said that the European Medicines Agency or EMA Committee for Medicinal Products for Human Use or CHMP issued a positive opinion to extend the current marketing authorization of SOLIRIS or eculizumab to include the treatment of neuromyelitis optica spectrum disorder or NMOSD in adult patients who are anti-aquaporin-4 antibody positive with a relapsing course of the disease.

The European Commission will review the CHMP opinion and the final decision is anticipated within two months.

NMOSD is a rare, devastating, complement-mediated disorder of the central nervous system characterized by relapses, also referred to as attacks. Each attack results in stepwise accumulation of disability, including blindness and paralysis and sometimes premature death.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The media mogul and Billionaire Sumner Redstone passed away on Tuesday at the age of 97, his family's holding company National Amusements said in a statement on Wednesday. He was Chairman Emeritus of ViacomCBS and chief executive officer of National Amusements. Customers in the U.S. are preferring digital or touchless payment methods due to concerns arising from the COVID-19 pandemic, a survey said. According to the survey by Rapyd Financial Network, the coronavirus pandemic has raised health and safety concerns around using cash and coins, and is accelerating the pre-existing trend toward digital transactions. American Airlines has extended its offer to waive change fees for customers who purchase tickets for travel, until December 31, 2020 in response to lower travel demand due to the coronavirus pandemic. This means that the travelers need not pay penalties for changing the origin and destination cities.
Follow RTT